Literature DB >> 21442381

Health-related quality of life and fatigue in patients with adrenal incidentaloma.

Darko Kastelan1, Fedja Dzubur, Tina Dusek, Tamara Poljicanin, Zeljka Crncevic-Orlic, Ivana Kraljevic, Mirsala Solak, Tanja Bencevic, Izet Aganovic, Nikola Knezevic, Zeljko Kastelan, Mirko Korsic.   

Abstract

The objective of the present study was to examine several dimensions of quality of life (QoL) and fatigue in patients with adrenal incidentaloma. This was a case-control study designed to analyze patient outcomes using three validated generic QoL questionnaires, EQ-5D, SF-36, and MFI-20, the results of which were compared to those obtained for age- and sex-matched controls. The study population comprised 139 consecutive patients with nonfunctioning adrenal masses (104 females, 35 males; age 59.1 ± 10.8) and 139 age- and sex-matched controls. Reduced QoL was found in patients with adrenal incidentaloma as compared to controls. Dimensions of QoL that were notably affected included mobility (P = 0.03), performance of usual activities (P = 0.002), and anxiety/depression (P = 0.04) as evaluated using the EQ-5D; physical functioning (P < 0.001), physical role (P < 0.001), general health (P < 0.001), vitality (P = 0.001), social functioning (P = 0.001), and emotional role (P < 0.001) as evaluated using the SF-36; and physical fatigue (P = 0.04) as assessed using the MFI-20 questionnaire. In addition, perceived health on a visual analogue scale was also significantly lower in patients than in controls (64.8 ± 19.2 vs. 77.1 ± 15.1; P < 0.001). Patients with adrenal incidentaloma reported reduced QoL and a higher level of physical fatigue compared to age- and sex-matched controls. This subject will benefit from further studies comparing QoL outcomes of laparoscopic adrenalectomy versus no treatment in patients with adrenal incidentaloma.

Entities:  

Mesh:

Year:  2011        PMID: 21442381     DOI: 10.1007/s12020-011-9456-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  22 in total

1.  Bone loss rate in adrenal incidentalomas: a longitudinal study.

Authors:  I Chiodini; M Torlontano; V Carnevale; G Guglielmi; M Cammisa; V Trischitta; A Scillitani
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

Review 2.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

3.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

Authors:  J E Ware; B Gandek
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

4.  Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma.

Authors:  O M Dekkers; A A van der Klaauw; A M Pereira; N R Biermasz; P J Honkoop; F Roelfsema; J W A Smit; J A Romijn
Journal:  J Clin Endocrinol Metab       Date:  2006-06-20       Impact factor: 5.958

5.  Long-term follow-up study of patients with adrenal incidentalomas.

Authors:  Rossella Libè; Chiara Dall'Asta; Laura Barbetta; Andrea Baccarelli; Paolo Beck-Peccoz; Bruno Ambrosi
Journal:  Eur J Endocrinol       Date:  2002-10       Impact factor: 6.664

6.  Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism.

Authors:  M Torlontano; I Chiodini; M Pileri; G Guglielmi; M Cammisa; S Modoni; V Carnevale; V Trischitta; A Scillitani
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

7.  Management of the clinically inapparent adrenal mass ("incidentaloma").

Authors:  Melvin M Grumbach; Beverly M K Biller; Glenn D Braunstein; Karen K Campbell; J Aidan Carney; Paul A Godley; Emily L Harris; Joseph K T Lee; Yolanda C Oertel; Mitchell C Posner; Janet A Schlechte; H Samuel Wieand
Journal:  Ann Intern Med       Date:  2003-03-04       Impact factor: 25.391

8.  Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism.

Authors:  Norlela Sukor; Cynthia Kogovsek; Richard D Gordon; Dianne Robson; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

9.  Quality of life in patients with a pituitary adenoma.

Authors:  Michelle D Johnson; C J Woodburn; Mary Lee Vance
Journal:  Pituitary       Date:  2003-09       Impact factor: 4.107

10.  The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

Authors:  E M Smets; B Garssen; B Bonke; J C De Haes
Journal:  J Psychosom Res       Date:  1995-04       Impact factor: 3.006

View more
  6 in total

1.  Depression: another cortisol-related comorbidity in patients with adrenal incidentalomas and (possible) autonomous cortisol secretion.

Authors:  A S Šojat; B Dunjić-Kostić; L V Marina; M Ivović; N V Radonjić; A Kendereški; A Ćirković; M Tančić-Gajić; Z Arizanović; S Mihajlović; S Vujović
Journal:  J Endocrinol Invest       Date:  2021-02-02       Impact factor: 4.256

Review 2.  Health-Related Quality of Life in Adrenocortical Carcinoma.

Authors:  Rebecca V Steenaard; Laura A Michon; Harm R Haak
Journal:  Cancers (Basel)       Date:  2019-10-08       Impact factor: 6.639

3.  Health-related quality of life in patients undergoing adrenalectomy: report from a Swedish National Audit.

Authors:  Lo Hallin Thompson; Erik Nordenström; Martin Almquist; Anders Bergenfelz
Journal:  Langenbecks Arch Surg       Date:  2019-11-26       Impact factor: 3.445

4.  Patient-reported impacts of a conservative management programme for the clinically inapparent adrenal mass.

Authors:  Andreas Muth; Charles Taft; Lilian Hammarstedt; Lena Björneld; Mikael Hellström; Bo Wängberg
Journal:  Endocrine       Date:  2012-12-20       Impact factor: 3.633

5.  Mental Health in Patients With Adrenal Incidentalomas: Is There a Relation With Different Degrees of Cortisol Secretion?

Authors:  Valentina Morelli; Alberto Ghielmetti; Alice Caldiroli; Silvia Grassi; Francesca Marzia Siri; Elisabetta Caletti; Francesco Mucci; Carmen Aresta; Elena Passeri; Flavia Pugliese; Annabella Di Giorgio; Sabrina Corbetta; Alfredo Scillitani; Maura Arosio; Massimiliano Buoli; Iacopo Chiodini
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

Review 6.  Frequently asked questions and answers (if any) in patients with adrenal incidentaloma.

Authors:  F Ceccato; M Barbot; C Scaroni; M Boscaro
Journal:  J Endocrinol Invest       Date:  2021-06-23       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.